Phospholipid liposome oral fluid

Abstract

The present invention relates to one kind of phosphatide liposome oral liquid for regulating blood fat and treating cardiac and cerebral vascular diseases caused by hyperlipemia. It consists of phosphatide liposome 1-20 wt%, vitamin E 0.07-0.375 wt%, vitamin C 0.45-0.85 wt%, evening primrose oil 0.32-0.56 wt% and water 75-98 wt%. Owing to the mutual action and replenishment of the components, the oral liquid has the relatively high effects of regulating blood fat, softening blood vessel, delaying senility and preventing various chronic diseases.

Description

technical field [0001] The invention relates to a phospholipid liposome oral liquid capable of effectively regulating blood fat and treating cardiovascular and cerebrovascular diseases caused by hyperlipidemia. Background technique [0002] Phospholipid liposomes are a new type of biomaterial, which are currently mainly used in targeted pharmaceuticals and cosmetic products. [0003] Liposomes are microcapsules with a bilayer membrane, similar in structure to human cells. Microcapsules have a diameter of several hundred to several thousand angstroms. According to its structure and diameter, it can be divided into single-layer vesicles, multi-layer large vesicles and single-layer small vesicles, and different vesicles can be prepared by different preparation processes. Wherein, the bilayer membrane of the liposome is similar to the human cell membrane, and is generally composed of surfactant molecules, with a thickness of about 50 angstroms. Bilayer membrane liposomes cons...

AI Technical Summary

Problems solved by technology

Although these inventive preparations have included phospholipid liposomes, due to the use of crude phospholipids or refined phospholipids, the actual phospholipid liposomes have not been used as raw materials. Vascular, anti-aging potential